M0246 HCPCS - INTRAVENOUS INFUSION, BAMLANIVIMAB AND ETESEVIMAB, INCLUDES INFUSION AND POST ADMINISTRATION MONITORING IN THE HOME OR RESIDENCE; THIS INCLUDES A BENEFICIARY'S HOME THAT HAS BEEN MADE PROVIDER BASED TO THE HOSPITAL DURING THE COVID 19 PUBLIC HEALTH EMERGENCY